Hypoxia, DNA repair and genetic instability

Cited by (1,000)

Items 501–600 of 1,000

1. Molecular basis of ‘hypoxic’ breast cancer cell radio-sensitization: phytochemicals converge on radiation induced Rel signaling
   Sheeja Aravindan, Mohan Natarajan, Terence S. Herman, Vibhudutta Awasthi, Natarajan Aravindan · 2013 · Radiation Oncology
2. N-acetyl-l-cysteine sensitizes pancreatic cancers to gemcitabine by targeting the NFκB pathway
   Suparna Qanungo, Joachim D. K. Uys, Yefim Manevich, Anne M. Distler, Brooke E. Shaner, Elizabeth Goodwin Hill, John J. Mieyal, John J. Lemasters, Danyelle M. Townsend, A. L. Nieminen · 2014 · Biomedicine & Pharmacotherapy
3. Hypoxia-Activated and Indomethacin-Mediated Theranostic Prodrug Releasing Drug On-Demand for Tumor Imaging and Therapy
   Xiaoran Peng, Jiaxin Gao, Yumeng Yuan, Haitong Liu, Weiyan Lei, Shenghui Li, Jinchao Zhang, Shuxiang Wang · 2019 · Bioconjugate Chemistry
4. Oncometabolites and the response to radiotherapy
   Kexu Xiang, Verena Jendrossek, Johann Matschke · 2020 · Radiation Oncology
5. The Refined Application and Evolution of Nanotechnology in Enhancing Radiosensitivity During Radiotherapy: Transitioning from Gold Nanoparticles to Multifunctional Nanomaterials
   Anqi Zhang, Lei Gao · 2023 · International Journal of Nanomedicine
6. Analysis of suitable prescribed isodose line fitting to planning target volume in stereotactic body radiotherapy using dynamic conformal multiple arc therapy
   Yohei Oku, Atsuya Takeda, Etsuo Kunieda, Yasunobu Sudo, Yoshikazu Oooka, Yousuke Aoki, Yoshiaki Shimouchi, Ryohei Nishina, Kazuhiro Nomura, Madoka Sugiura et al. · 2011 · Practical Radiation Oncology
7. Endogenous and radiation-induced expression of γH2AX in biopsies from patients treated for carcinoma of the uterine cervix
   Peggy L. Olive, Carmen Adriana Banuelos, Ralph E. Durand, Joo-Young Kim, Christina Aquino‐Parsons · 2009 · Radiotherapy and Oncology
8. « Dose-painting » : mythe ou réalité ?
   Stéphane Supiot, A. Lisbona, François Paris, D. Azria, P. Fenoglietto · 2010 · Cancer/Radiothérapie
9. Use of Molecular Biomarkers to Quantify the Spatial Distribution of Effects of Anticancer Drugs in Solid Tumors
   Jasdeep K. Saggar, Andrea S. Fung, Krupa J. Patel, Ian F. Tannock · 2013 · Molecular Cancer Therapeutics
10. Down-Regulation of NDRG1 Promotes Migration of Cancer Cells during Reoxygenation
    Liang‐Chuan Lai, Yi-Yu Su, Kuo‐Chih Chen, Mong‐Hsun Tsai, Yuh‐Pyng Sher, Tzu‐Pin Lu, Chien‐Yueh Lee, Eric Yao-Yu Chuang · 2011 · PLoS ONE
11. Metabolic adaptation of tissues to stress releases metabolites influencing innate immunity
    Philippe Naquet, Caroline Giessner, Franck Galland · 2015 · Current Opinion in Immunology
12. HSP90 inhibition induces cytotoxicity via down-regulation of Rad51 expression and DNA repair capacity in non-small cell lung cancer cells
    Jen‐Chung Ko, Huang-Jen Chen, Yu‐Ching Huang, Sheng-Chieh Tseng, Shao‐Hsing Weng, Ting‐Yu Wo, Yi‐Jhen Huang, Hsien‐Chun Chiu, Min‐Shao Tsai, Robin Y.‐Y. Chiou et al. · 2012 · Regulatory Toxicology and Pharmacology
13. Targeting lung cancer through inhibition of checkpoint kinases
    Randi G. Syljuåsen, Grete Hasvold, Sissel Hauge, Åslaug Helland · 2015 · Frontiers in Genetics
14. Profiling of a panel of radioresistant prostate cancer cells identifies deregulation of key miRNAs
    Niamh McDermott, Armelle Meunier, Simon C. K. Wong, Nicolae‐Viorel Buchete, Laure H. Marignol · 2017 · Clinical and Translational Radiation Oncology
15. Switching off malignant mesothelioma: exploiting the hypoxic microenvironment
    Noushin Nabavi, Kevin L. Bennewith, Andrew Churg, Yuzhuo Z. Wang, Colin C. Collins, Luciano Mutti · 2017 · Genes & Cancer
16. The Match between Molecular Subtypes, Histology and Microenvironment of Pancreatic Cancer and Its Relevance for Chemoresistance
    Javier Martínez‐Useros, Mario Martin-Galan, Jesús García‐Foncillas · 2021 · Cancers
17. A versatile nanoplatform based on multivariate porphyrinic metal–organic frameworks for catalytic cascade-enhanced photodynamic therapy
    Shen‐Zhen Ren, Xiaohua Zhu, Bin Wang, Ming Liu, Shukai Li, Yu‐Shun Yang, Hailong An, Hai‐Liang Zhu · 2021 · Journal of Materials Chemistry B
18. The Potential of Photoacoustic Imaging in Radiation Oncology
    Thierry L Lefebvre, Emma L. Brown, Lina Hacker, Thomas R. Else, Mariam‐Eleni Oraiopoulou, Michal R. Tomaszewski, Rajesh Jena, Sarah E. Bohndiek · 2022 · Frontiers in Oncology
19. Physiological Mechanisms of Treatment Resistance
    Peter W. Vaupel · 2009 · Medical radiology
20. A combined pharmacokinetic model for the hypoxia-targeted prodrug PR-104A in humans, dogs, rats and mice predicts species differences in clearance and toxicity
    Kashyap Patel, Steve Choy, Kevin Owen Hicks, Teresa J. Melink, Nicholas H. G. Holford, William Robert Wilson · 2010 · Cancer Chemotherapy and Pharmacology
21. SirT1 regulates radiosensitivity of hepatoma cells differently under normoxic and hypoxic conditions
    Yuexia Xie, Jianghong Zhang, Shuang Ye, Mingyuan He, Ruiping Ren, Dexiao Yuan, Chunlin Shao · 2012 · Cancer Science
22. Captopril and S-nitrosocaptopril as potent radiosensitizers: Comparative study and underlying mechanisms
    Bénédicte F. Jordan, Julie Peeterbroeck, Oussama Karroum, Caroline Diepart, Julie Magat, Vincent Grégoire, Bernard Gallez · 2010 · Cancer Letters
23. Positron Emission Tomography/Computed Tomography Imaging of Residual Skull Base Chordoma Before Radiotherapy Using Fluoromisonidazole and Fluorodeoxyglucose: Potential Consequences for Dose Painting
    Hamid Mammar, Khaldoun Kerrou, V. Nataf, Dominique Pontvert, Stéphane Clémenceau, Guillaume Lot, Bernard George, Marc Polivka, Karima Mokhtari, R. Ferrand et al. · 2012 · International Journal of Radiation Oncology*Biology*Physics
24. Downregulation of DNA repair proteins and increased DNA damage in hypoxic colon cancer cells is a therapeutically exploitable vulnerability
    Jennifer M.J. Jongen, Lizet M. van der Waals, Kari Trumpi, Jamila Laoukili, Niek A. Peters, Susanne J. van Schelven, Klaas M. Govaert, Inne H.M. Borel Rinkes, Onno Kranenburg · 2017 · Oncotarget
25. Recent Development on Controlled Synthesis of Mn‐Based Nanostructures for Bioimaging and Cancer Therapy
    Juan Ruan, Haisheng Qian · 2021 · Advanced Therapeutics
26. Involvement of HIF-1α in the Detection, Signaling, and Repair of DNA Double-Strand Breaks after Photon and Carbon-Ion Irradiation
    Anne‐Sophie Wozny, Arnaud Gauthier, Gersende Alphonse, Céline Malésys, Virginie Varoclier, Michaël Beuve, Delphine Brichart-Vernos, Nicolas Magné, Nicolas Vial, Dominique Ardail et al. · 2021 · Cancers
27. Zwitterionic Block Copolymer Prodrug Micelles for pH Responsive Drug Delivery and Hypoxia-Specific Chemotherapy
    Jianyang Zhao, Yi‐Yang Peng, Diana Diaz‐Dussan, John White, Wei Duan, Lingxue Kong, Ravin Narain, Xiaojuan Hao · 2021 · Molecular Pharmaceutics
28. Hypoxia and Its Influence on Radiotherapy Response of HPV-Positive and HPV-Negative Head and Neck Cancer
    Marilyn Wegge, Rüveyda Dok, Sandra Nuyts · 2021 · Cancers
29. Enzyme-activated prodrugs and their release mechanisms for the treatment of cancer
    Xinyu Li, Fangjun Huo, Yongbin Zhang, Fangqin Cheng, Caixia Yin · 2022 · Journal of Materials Chemistry B
30. Design of silicon-based misonidazole analogues and 18F-radiolabelling
    Pierre Bohn, Abdallah Deyine, Rabah Azzouz, Laëtitia Bailly, Catherine Fiol‐Petit, Laurent Bischoff, Corinne Fruit, Francis Marsais, Pierre Véra · 2009 · Nuclear Medicine and Biology
31. Modelling and simulation of the influence of acute and chronic hypoxia on [18F]fluoromisonidazole PET imaging
    David Mönnich, Esther G.C. Troost, Johannes H.A.M. Kaanders, Wim J.G. Oyen, Markus L. Alber, Daniela Thorwarth · 2012 · Physics in Medicine and Biology
32. Enzyme-Activated Generation of Reactive Oxygen Species from Heterocyclic N-Oxides under Aerobic and Anaerobic Conditions and Its Relevance to Hypoxia-Selective Prodrugs
    Xiulong Shen, Kent S. Gates · 2019 · Chemical Research in Toxicology
33. Insights into Hypoxia: Non-invasive Assessment through Imaging Modalities and Its Application in Breast Cancer
    Isaac Daimiel Naranjo · 2019 · Journal of Breast Cancer
34. Recent advances in hypoxia-activated compounds for cancer diagnosis and treatment
    Xiaoyu Yuan, Zhiying Xie, Taotao Zou · 2024 · Bioorganic Chemistry
35. Engineering tumor-oxygenated nanomaterials: advancing photodynamic therapy for cancer treatment
    Tingting Zuo, Xiaodie Li, Xuan Ma, Ye Zhang, Xueru Li, Xuehai Fan, Mingze Gao, Donglin Xia, Huijun Cheng · 2024 · Frontiers in Bioengineering and Biotechnology
36. Targeting Hypoxic Prostate Tumors Using the Novel Hypoxia-Activated Prodrug OCT1002 Inhibits Expression of Genes Associated with Malignant Progression
    Heather Nesbitt, Niall M. Byrne, S. Nicole Williams, Louise Ming, Jenny Worthington, Rachel J. Errington, Laurence H. Patterson, Paul J. Smith, STEPHANIE R. McKEOWN, Declan J. McKenna · 2016 · Clinical Cancer Research
37. Extremely Effective Chemoradiotherapy by Inducing Immunogenic Cell Death and Radio-Triggered Drug Release under Hypoxia Alleviation
    Chunqi Zhu, Xiaomeng Guo, Lihua Luo, Zhe Wu, Zhenyu Luo, Mengshi Jiang, Junlei Zhang, Bing Qin, Yingying Shi, Yan Lou et al. · 2019 · ACS Applied Materials & Interfaces
38. Small Molecule Fluorescent Probes for Sensing and Bioimaging of Nitroreductase
    Samarpita Das, Harish Kumar Indurthi, Pulkit Asati, Deepak Kumar Sharma · 2022 · ChemistrySelect
39. Hypoxia suppresses chemotherapeutic drug-induced p53 Serine 46 phosphorylation by triggering HIPK2 degradation
    Jutta Moehlenbrink, Nadja Bitomsky, Thomas G. Hofmann · 2009 · Cancer Letters
40. Chromosomal aberrations in peripheral blood lymphocytes exposed to a mixed beam of low energy neutrons and gamma radiation
    Andrzej Wójcik, G�nter Obe, Halina Lisowska, Joanna Czub, NIEVAART Victor Alexander, R. Moss, R. Huiskamp, Wolfgang A G Sauerwein · 2012 · Journal of Radiological Protection
41. Systemic DNA damage accumulation under in vivo tumor growth can be inhibited by the antioxidant Tempol
    Alexandros G. Georgakilas, Christophe E. Redon, Nicholas F. Ferguson, Thomas B. Kryston, Palak R. Parekh, Jennifer S. Dickey, Asako Nakamura, James B. Mitchell, William M. Bonner, Olga A. Martin · 2014 · Cancer Letters
42. Vascular responses to radiotherapy and androgen-deprivation therapy in experimental prostate cancer
    Kathrine Røe Redalen, Lars Tore Gyland Mikalsen, Albert J. van der Kogel, Johan Bussink, Heidi Lyng, Anne Hansen Ree, Laure H. Marignol, Dag Rune Olsen · 2012 · Radiation Oncology
43. Anionic iridium(III) complexes and their conjugated polymer soft salts for time-resolved luminescent detection of intracellular oxygen levels
    Shujuan Liu, Liuwei Wei, Song Guo, Jiayang Jiang, Pinglin Zhang, Jianmei Han, Yun Ma, Qiang Zhao · 2018 · Sensors and Actuators B Chemical
44. Metabolic challengers selecting tumor-persistent cells
    Caterina Mancini, Giulia Lori, Erica Pranzini, Maria Letizia Taddei · 2023 · Trends in Endocrinology and Metabolism
45. Acquired and Intrinsic Resistance to Colorectal Cancer Treatment
    Romina Briffa, Simon P. Langdon, Godfrey Grech, David James Harrison · 2018 · InTech eBooks
46. ERO1α is a novel endogenous marker of hypoxia in human cancer cell lines
    Norio Takei, Akihiro Yoneda, Marina Kosaka, Kaori Sakai, Yasuaki Tamura · 2019 · BMC Cancer
47. Neural phosphoproteomics of a chronic hypoxia model—Lymnaea stagnalis
    Lorelei B. Silverman‐Gavrila, Tom Z. Lu, Rene Christopher Prashad, Nasrin Nejatbakhsh, Milton P. Charlton, Zhong‐Ping Feng · 2009 · Neuroscience
48. KS900: A hypoxia-directed, reductively activated methylating antitumor prodrug that selectively ablates O6-alkylguanine-DNA alkyltransferase in neoplastic cells
    Raymond P. Baumann, Kimiko Ishiguro, Philip G. Penketh, Krishnamurthy Shyam, Rui Zhu, Alan C. Sartorelli · 2011 · Biochemical Pharmacology
49. Hsp90 inhibition by NVP-AUY922 and NVP-BEP800 decreases migration and invasion of irradiated normoxic and hypoxic tumor cell lines
    Susanne Hartmann, Nadine Günther, Marlene Biehl, Astrid Katzer, Sebastian Kuger, Eike Worschech, Vladimir L. Sukhorukov, Georg Krohne, Heiko Zimmermann, Michael P. Flentje et al. · 2013 · Cancer Letters
50. Downregulation of AIF by HIF-1 contributes to hypoxia-induced epithelial–mesenchymal transition of colon cancer
    Zhong Xiong, Meng Guo, Yun Yu, Feifei Zhang, Meng-Kai Ge, Guoqiang Chen, Shao-Ming Shen · 2016 · Carcinogenesis
51. Robust optimization with time-dependent uncertainty in radiation therapy
    Omid Nohadani, Arkajyoti Roy · 2017 · IISE Transactions on Healthcare Systems Engineering
52. The Transcription Factor Hif-1 Enhances the Radio-Resistance of Mouse MSCs
    Irene Calvo‐Asensio, Eugène Dillon, Noel Francis Lowndes, Rhodri Ceredig · 2018 · Frontiers in Physiology
53. DCE-MRI of Sunitinib-Induced Changes in Tumor Microvasculature and Hypoxia: A Study of Pancreatic Ductal Adenocarcinoma Xenografts
    Catherine Sem Wegner, Anette Hauge, Trude G. Simonsen, Jon‐Vidar Gaustad, Lise Mari K. Andersen, Einar K. Rofstad · 2018 · Neoplasia
54. Severe hypoxia increases expression of ATM and DNA-PKcs and it increases their activities through Src and AMPK signaling pathways
    Takuma Hashimoto, Yasuhiko Murata, Yusuke Urushihara, Soichiro Shiga, Kazuya Takeda, Yoshio Hosoi · 2018 · Biochemical and Biophysical Research Communications
55. Prognostic value of tumor necrosis in gastrointestinal stromal tumor
    Mengshi Yi, Lin Xia, Yan Zhou, Xiaoting Wu, Wen Zhuang, Yi Chen, Rui Zhao, Qianyi Wan, Liang Du, Yong Zhou · 2019 · Medicine
56. Melatonin: Regulation of Prion Protein Phase Separation in Cancer Multidrug Resistance
    Doris Loh, Russel Joseph Reiter · 2022 · Molecules
57. A silver lining on the horizon for glioblastoma
    Jonathan P.S. Knisely, Joachim M. Baehring · 2009 · The Lancet Oncology
58. Castration Therapy of Prostate Cancer Results in Downregulation of HIF-1α Levels
    Firas L. T. Al-Ubaidi, Niklas Schultz, Lars Egevad, Torvald Granfors, Thomas Helleday · 2012 · International Journal of Radiation Oncology*Biology*Physics
59. Mechanistic Insights into Molecular Targeting and Combined Modality Therapy for Aggressive, Localized Prostate Cancer
    Alan Dal Pra, Jennifer A. Locke, Gerben R. Borst, Stéphane Supiot, Robert Glen Bristow · 2016 · Frontiers in Oncology
60. Role of Bladder Cancer Metabolic Reprogramming in the Effectiveness of Immunotherapy
    Mathijs Scholtes, Florus C. de Jong, Tahlita C.M. Zuiverloon, Dan Theodorescu · 2021 · Cancers
61. Factors That Affect the Formation of Chromosomal Translocations in Cells
    Reynand Jay Canoy, Anna Shmakova, Anna A. Karpukhina, Mikhail V. Shepelev, Diego Germini, Yegor S Vassetzky · 2022 · Cancers
62. Targeting tumor-stroma communication by blocking endothelin-1 receptors sensitizes high-grade serous ovarian cancer to PARP inhibition
    Piera Tocci, Celia Román, Rosanna Sestito, Valeriana Di Castro, Andrea Sacconi, Ivan Molineris, Francesca Paolini, Mariantonia Carosi, Giovanni Tonon, Giovanni Blandino et al. · 2023 · Cell Death and Disease
63. Radio-resistance of hypoxic tumors: exploring the effects of oxygen and X-ray radiation on non-small lung cancer cell lines
    Rachel Hanley, Francesca Pagliari, Daniel García-Calderón, Joana Fernandes Guerreiro, Géraldine Genard, Jeannette Jansen, Clelia Nisticò, Maria Grazia Marafioti, Luca Tirinato, Joao Carlos Seco · 2023 · Radiation Oncology
64. Crosstalk between hypoxia-induced pyroptosis and immune escape in cancer: From mechanisms to therapy
    Seyed Mohammadmahdi Meybodi, Mahsa Ejlalidiz, Mohammadsadegh Rezaeian Manshadi, Mohammad Raeisi, Maryam Zarin, Zahra Kalhor, Mohammadreza Saberiyan, Michael Richard Hamblin · 2024 · Critical Reviews in Oncology/Hematology
65. Emerging role of autophagy during ischemia-hypoxia and reperfusion in hepatocellular carcinoma
    Weihua Qiu · 2012 · International Journal of Oncology
66. Regulation of mammalian target of rapamycin complex 1 (mTORC1) by hypoxia: causes and consequences
    Hakan Çam, Peter J. Houghton · 2011 · Targeted Oncology
67. Extranodal spread in the neck: MRI detection on the basis of pixel‐based time‐signal intensity curve analysis
    Misa Sumi, Takashi Nakamura · 2011 · Journal of Magnetic Resonance Imaging
68. Radiosensitising agents for the radiotherapy of cancer: novel molecularly targeted approaches
    Francis J. Dumont, Anaïs Altmeyer, Pierre L. Bischoff · 2009 · Expert Opinion on Therapeutic Patents
69. Tumour hypoxia determines the potential of combining mTOR and autophagy inhibitors to treat mammary tumours
    Emmanuel Seront, Romain Boidot, Caroline Bouzin, Oussama Karroum, Bénédicte F. Jordan, Bernard Gallez, J-P Machiels, Olivier Féron · 2013 · British Journal of Cancer
70. A Tumor Microenvironment-Responsive Self-Oxygenating Nanoplatform for Dual-Enhanced Cuproptosis and Sonodynamic Synergistic Immunotherapy
    Yikai Tang, Lei Ge, Dan Yan Zhu, Ruofan Hu, Weizhi Chen, Zhen Cheng Xu, Xiqun Jiang · 2025 · ACS Nano
71. Sickle Erythrocytes Target Cytotoxics to Hypoxic Tumor Microvessels and Potentiate a Tumoricidal Response
    David S. Terman, Benjamin L. Viglianti, Rahima Zennadi, Diane R. Fels, Richard J. Boruta, Hong Yuan, Mathew R. Dreher, Gerald Arthur Grant, Zahid N. Rabbani, Ejung Moon et al. · 2013 · PLoS ONE
72. A gene for all seasons: The evolutionary consequences of HIF-1 in carcinogenesis, tumor growth and metastasis
    Ranjini Bhattacharya, Joel S. Brown, Robert A. Gatenby, Arig Ibrahim‐Hashim · 2024 · Seminars in Cancer Biology
73. The relevance of molecular biomarkers in cervical cancer patients treated with radiotherapy.
    Sarah Sabrine Kilic, Bernadette M. Cracchiolo, Molly Gabel, Bruce George Haffty, Omar Mahmoud · 2015 · Europe PMC (PubMed Central)
74. DNA damage response in peritumoral regions of oesophageal cancer microenvironment
    Han He, D. Tian, Jincheng Guo, Mingyao Liu, Z. Chen, Freddie Charles Hamdy, Thomas Helleday, Min Su, Songmin Ying · 2012 · Carcinogenesis
75. Hypoxia‐induced alterations of G2 checkpoint regulators
    Grete Hasvold, Christin Lund‐Andersen, Malin Lando, Sebastian Patzke, Sissel Hauge, Zhenhe Suo, Heidi Lyng, Randi G. Syljuåsen · 2016 · Molecular Oncology
76. Aryl Hydrocarbon Receptor Activates NDRG1 Transcription under Hypoxia in Breast Cancer Cells
    En-Yu Li, Wei‐Yung Huang, Ya‐Chu Chang, Mong‐Hsun Tsai, Eric Yao-Yu Chuang, Qian-Yu Kuok, Shih-Ting Bai, Lo-Yun Chao, Yuh‐Pyng Sher, Liang‐Chuan Lai · 2016 · Scientific Reports
77. Non-standard radiotherapy fractionations delay the time to malignant transformation of low-grade gliomas
    Araceli Henares-Molina, Sébastien Benzekry, Pedro C. Lara, Marcial García‐Rojo, Víctor M. Pérez‐García, Alicia Martínez‐González · 2017 · PLoS ONE
78. Differential expression of hypoxia-inducible factors related to the invasiveness of epithelial ovarian cancer
    Ho-Jun Shih, Hsin‐Fang Chang, Chi‐Ling Chen, Pao‐Ling Torng · 2021 · Scientific Reports
79. Hsp90 inhibitor NVP-AUY922 enhances radiation sensitivity of tumor cell lines under hypoxia
    Cholpon S. Djuzenova, Christina Blassl, Konstanze Roloff, Sebastian Kuger, Astrid Katzer, Natalia Niewidok, Nadine Günther, Bülent Polat, Vladimir L. Sukhorukov, Michael P. Flentje · 2012 · Cancer Biology & Therapy
80. Intracellular Oxygen Transient Quantification in Vivo During Ultra-High Dose Rate FLASH Radiation Therapy
    Arthur F. Pétusseau, Megan Clark, Petr Brůža, David J. Gladstone, Brian W. Pogue · 2024 · International Journal of Radiation Oncology*Biology*Physics
81. miR‐495 and miR‐5688 are down‐regulated in non‐small cell lung cancer under hypoxia to maintain interleukin‐11 expression
    Meng Zhao, Jiao Chang, Ran Liu, Yahui Liu, Jin Qi, Yanhui Wang, Xinwei Zhang, Lu Qiao, Jin Hui Yu, Haohua An et al. · 2020 · 癌症：英文版
82. [18F]-Fluoromisonidazole Positron Emission Tomography/Computed Tomography Visualization of Tumor Hypoxia in Patients With Chordoma of the Mobile and Sacrococcygeal Spine
    Matthew D. Cheney, Yen‐Lin Chen, Ruth Lim, Barbara K. Winrich, Anca‐Ligia Grosu, Alexei V. Trofimov, Nicolas Depauw, Helen Alice Shih, Joseph Hasbrouck Schwab, Francis John Hornicek et al. · 2014 · International Journal of Radiation Oncology*Biology*Physics
83. Hypoxia‐inducible factors – regulation, role and comparative aspects in tumourigenesis
    Adam Espe Hansen, Annemarie Thuri Kristensen, Ian G. Law, Jesper Tranekjær Jørgensen, Svend Aage Engelholm · 2010 · Veterinary and Comparative Oncology
84. Combined therapies of antithrombotics and antioxidants delayin silicobrain tumour progression
    Alicia Martínez‐González, Mario Durán‐Prado, Gabriel F. Calvo, Francisco Javier Alcain, Luís A. Pérez-Romasanta, Víctor M. Pérez‐García · 2014 · Mathematical Medicine and Biology A Journal of the IMA
85. Selective radiosensitization of hypoxic cells using BCCA621C: a novel hypoxia activated prodrug targeting DNA-dependent protein kinase
    Kirstin E. Lindquist, Jordan Cran, K. Kordic, Peter C. Chua, Geoffrey C. Winters, Jason Samuel Tan, Jerome Lozada, Alastair Hugh Kyle, James Evans, Andrew Ivor Minchinton · 2013 · Tumor Microenvironment and Therapy
86. The Effect of Silencing HIF-1α Gene in BxPC-3 Cell Line on Glycolysis-Related Gene Expression, Cell Growth, Invasion, and Apoptosis
    Yi Jiang, Guohao Wu, Guodong He, Qiulin Zhuang, Qiulei Xi, Bo Zhang, Yusong Han, Jing Susan Fang · 2015 · Nutrition and Cancer
87. Decreased ATF4 expression as a mechanism of acquired resistance to long-term amino acid limitation in cancer cells
    Florent Mesclon, Sarah Lambert-Langlais, Valérie Carraro, Laurent Parry, Isabelle Hainault, Céline Jousse, Anne‐Catherine Maurin, Alain Bruhat, Pierre Fafournoux, Julien Avérous · 2017 · Oncotarget
88. Targeting DNA repair for precision radiotherapy: Balancing the therapeutic ratio
    Osman Mahamud, Jonathan So, Melvin L.K. Chua, Robert Glen Bristow · 2017 · Current Problems in Cancer
89. Complex DNA structures trigger copy number variation across the Plasmodium falciparum genome
    Adam C. Huckaby, Claire S Granum, Maureen A. Carey, Karol A. Szlachta, Basel Maher Al-Barghouthi, Yuh‐Hwa Wang, Jennifer L. Güler · 2018 · Nucleic Acids Research
90. The effect of cycling hypoxia on MCF-7 cancer stem cells and the impact of their microenvironment on angiogenesis using human umbilical vein endothelial cells (HUVECs) as a model
    Fuad Alhawarat, Hana M. Hammad, Majd S. Hijjawi, Ahmad Sharab, Duaa Azmi Abuarqoub, Mohammad A. Al Shhab, Malek A. Zihlif · 2019 · PeerJ
91. Radiotherapy and the cellular DNA damage response: current and future perspectives on head and neck cancer treatment
    Maria Rita Fabbrizi, Jason Luke Parsons · 2020 · Cancer Drug Resistance
92. Melatonin as a Therapeutic Agent for the Inhibition of Hypoxia-Induced Tumor Progression: A Description of Possible Mechanisms Involved
    Sepideh Bastani, Moloud Akbarzadeh, Yeganeh Rastgar Rezaei, Ali Farzane, Mohammad Nouri, Mahsa Mollapour Sisakht, Amir Fattahi, Maryam Akbarzadeh, Russel Joseph Reiter · 2021 · International Journal of Molecular Sciences
93. Tumor microenvironment determines response to a heat-activated thermosensitive liposome formulation of cisplatin in cervical carcinoma
    Dou, Yannan N., Chaudary, Naz, Chang, Martin C., Dunne, Michael, Huang, Huang, Jaffray, David A., Milosevic, Michael, Allen, Christine · 2017 · Journal of Controlled Release
94. Metabolic Constrains Rule Metastasis Progression
    Niccolò Roda, Valentina Gambino, Marco Giorgio · 2020 · Cells
95. Chromosomal Instability, Selection and Competition: Factors That Shape the Level of Karyotype Intra-Tumor Heterogeneity
    Tom van den Bosch, Sarah Derks, Daniël M. Miedema · 2022 · Cancers
96. Nanocatalase-Based Oxygen-Generating Nanocarriers for Active Oxygen Delivery to Relieve Hypoxia in Pancreatic Cancer
    Xiaoxue Han, Yoon Jeong, Joseph Irudayaraj · 2022 · ACS Applied Nano Materials
97. Non-homologous end joining pathway is the major route of protection against 4β-hydroxywithanolide E-induced DNA damage in MCF-7 cells
    B. J. You, Yang‐Chang Wu, Choa‐Hsun Lee, H.-Z. Lee · 2013 · Food and Chemical Toxicology
98. Three-dimensional culture promotes reconstitution of the tumor-specific hypoxic microenvironment under TGFβ stimulation
    Hideki Marushima · 2011 · International Journal of Oncology
99. Hypoxia- and acidosis-driven aberrations of secreted microRNAs in endometrial cancer in vitro
    Julia Eismann, Marc Hirschfeld, Thalia Erbes, Gerta Rücker, Markus Jäger, Andrea Ritter, Daniela Weiß, Gerald Gitsch, Sebastian Mayer · 2017 · Oncology Reports
100. Integrated omics profiling identifies hypoxia-regulated genes in HCT116 colon cancer cells
     Jeng-Ting Chen, Chien-Chun Liu, Jau‐Song Yu, Hung‐Hsuan Li, Ming‐Chih Lai · 2018 · Journal of Proteomics